Abstract:Hepatic fibrosis is an important pathological manifestation of chronic schistosome infection. Patients with advanced schistosomiasis show varying degrees of abnormalities in liver fibrosis indicators and bilirubin metabolism. However, the relationship between hepatic fibrosis in schistosomiasis and dysregulated bilirubin metabolism remains unclear. In this study, we observed a positive correlation between total bilirubin levels and the levels of ALT, AST, LN, and CIV in patients with advanced schistosomiasis. Additionally, we established mouse models at different time points following S. japonicum infection. As the infection time increased, liver fibrosis escalated, while liver UGT1A1 consistently exhibited a low expression, indicating impaired glucuronidation of bilirubin metabolism in mice. In vitro experiments suggested that SEA may be a key inhibitor of hepatic UGT1A1 expression after schistosome infection. Furthermore, a high concentration of bilirubin activated the NF-κB signaling pathway in L-O2 cells in vitro. These findings suggested that the dysregulated glucuronidation of bilirubin caused by S. japonicum infection may play a significant role in schistosomiasis liver fibrosis through the NF-κB signaling pathway.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore how abnormal metabolism of bilirubin, a heme metabolite, exacerbates hepatitis and liver fibrosis caused by schistosomiasis japonica through the NF - κB signaling pathway. Specifically, the researchers observed a positive correlation between total bilirubin levels and levels of liver injury indicators (such as ALT, AST) and liver fibrosis markers (such as LN, CIV) in patients with advanced schistosomiasis japonica. In addition, by establishing mouse infection models at different time points, the study found that as the infection time increased, liver fibrosis gradually worsened, and UGT1A1 expression in the liver remained persistently low, indicating impaired bilirubin metabolism. In vitro experiments further showed that SEA may be a key inhibitory factor for UGT1A1 expression in hepatocytes after infection, and high - concentration bilirubin can activate the NF - κB signaling pathway in L - O2 cells. These findings suggest that abnormal bilirubin metabolism caused by schistosomiasis japonica infection may play an important role in schistosomiasis - induced liver fibrosis through the NF - κB signaling pathway. ### Main research questions: 1. **Association between abnormal bilirubin metabolism and liver fibrosis**: Explore whether abnormal bilirubin metabolism is related to liver fibrosis in patients with schistosomiasis japonica. 2. **Role of the NF - κB signaling pathway**: Investigate whether abnormal bilirubin metabolism exacerbates liver fibrosis through the NF - κB signaling pathway. 3. **Effect of SEA on UGT1A1 expression**: Analyze whether SEA (soluble egg antigen) inhibits UGT1A1 expression, thereby affecting bilirubin metabolism. ### Research methods: - **Clinical data analysis**: Analyze blood biochemical indicators of 745 patients with advanced schistosomiasis japonica to explore the correlation between total bilirubin and liver injury and liver fibrosis indicators. - **Mouse models**: Establish mouse models of schistosomiasis japonica infection at different time points to observe changes in liver fibrosis and UGT1A1 expression after infection. - **In vitro experiments**: Use LX - 2 and L - O2 cell lines to study the effects of SEA on cell proliferation, apoptosis, and UGT1A1 gene expression. ### Main findings: - **Clinical data**: Total bilirubin levels are positively correlated with liver injury indicators (ALT, AST) and liver fibrosis markers (LN, CIV). - **Mouse models**: As the infection time prolongs, liver fibrosis gradually worsens and UGT1A1 expression remains persistently low. - **In vitro experiments**: SEA significantly inhibits the proliferation of LX - 2 and L - O2 cells, promotes cell apoptosis, and inhibits UGT1A1 mRNA expression. High - concentration bilirubin can activate the NF - κB signaling pathway in L - O2 cells. These findings provide a new perspective for understanding the pathological mechanism of schistosomiasis japonica - induced liver fibrosis and may offer new ideas for treating this disease.

Dysregulated Glucuronidation of Bilirubin Exacerbates Liver Inflammation and Fibrosis in Schistosomiasis Japonica through the NF-κB Signaling Pathway

[Re-Understanding of Liver Cirrhosis Induced by Schistosomiasis Japonica].

Effect of hepatocyte damage in hepatic fibrogenesis of patients infected with Schistosoma japonicum

Single-cell RNA sequencing to dissect the immunological network of liver fibrosis in Schistosoma japonicum-infected mice

Pathology and molecular mechanisms of Schistosoma japonicum-associated liver fibrosis

[Expression of Smad Proteins in the Process of Liver Fibrosis in Mice Infected with Schistosoma Japonicum].

Single-Cell Analysis Reveals the Cellular and Molecular Changes of Liver Injury and Fibrosis in Mice During the Progression of Schistosoma japonicum Infection

Longitudinal Immune Profiling Highlights CD4+ T Cell Exhaustion Correlated with Liver Fibrosis in Schistosoma japonicum Infection

Lipid Metabolism Regulate the Inflammatory Microenvironment in the Hepatic Fibrosis Induced by Schistosoma Japonicum Infection in China: A Genotype-Phenotype Association Study

NLRP3 inflammasome activation results in liver inflammation and fibrosis in mice infected with Schistosoma japonicum in a Syk-dependent manner

Pathological Changes in Hepatic Sinusoidal Endothelial Cells in Schistosoma japonicum-Infected Mice

NLRP3 inflammasome inhibition decreases Schistosomiasis japonica-induced granulomatous inflammation and fibrosis in BALB/c mice

IFN‐γ Gene Therapy by Intrasplenic Hepatocyte Transplantation: a Novel Strategy for Reversing Hepatic Fibrosis in Schistosoma Japonicum‐infected Mice

Association of CX3CL1 and CX3CR1 Expression with Liver Fibrosis in a Mouse Model of Schistosomiasis

Inhibition of hepatic natural killer cell function via the TIGIT receptor in schistosomiasis-induced liver fibrosis

Blockade Of Pd-1 Signaling Enhances Th2 Cell Responses And Aggravates Liver Immunopathology In Mice With Schistosomiasis Japonica

Autophagy in hepatic progenitor cells modulates exosomal miRNAs to inhibit liver fibrosis in schistosomiasis

The Dynamics of Hepatic Fibrosis Related to Schistosomiasis and Its Risk Factors in a Cohort of China

Induction of hepatic fibrosis in mice with schistosomiasis by extracellular microRNA-30 derived from Schistosoma japonicum eggs

The egg ribonuclease SjCP1412 accelerates liver fibrosis caused by Schistosoma japonicum infection involving damage-associated molecular patterns (DAMPs)

miR-182-5p attenuates <italic>Schistosoma japonicum</italic>-induced hepatic fibrosis by targeting tristetraprolin